Semler Scientific

San Jose, United States Founded: 2007 • Age: 19 yrs Listed Acquired By Strive
Point-of-care devices for peripheral arterial disease screening are developed.

About Semler Scientific

Semler Scientific is a publicly listed company based in San Jose (United States) founded in 2007, and was acquired by Strive in January 2026. Point-of-care devices for peripheral arterial disease screening are developed. The company has 79 employees. Its website semlerscientific.com draws about 24 thousand monthly visits. Semler Scientific offers products and services including QuantaFlo. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is Semler Scientific, Inc.

Company details

Semler Scientific was established in 2007 in San Jose, United States, within the medical device sector. Focus is placed on creating in-office tools for detecting peripheral arterial disease through blood flow assessments. QuantaFlo is utilized as a primary point-of-care test, while WellChec serves as a platform for screening multiple chronic conditions. Operations emphasize accessible diagnostic services for healthcare providers across the region.

  • Headquarters San Jose, United States
  • Employees 79
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website semlerscientific.com
  • Social LinkedIn
  • Acquired by Strive (Jan 2026)
  • Legal Name Semler Scientific, Inc.
Key Metrics
  • Annual Revenue
    $56.29 M (USD)
    -17.44
    as on Dec 31, 2024
  • Net Profit
    $40.9 M (USD)
    98.7
    as on Dec 31, 2024
  • EBITDA
    $21.51 M (USD)
    -8.8
    as on Dec 31, 2024
  • Latest Funding Round
    $498.6K (USD), Post-IPO

    Mar 2015

  • Investors
  • Employee Count
    79
  • Acquired by
    Strive

    (Jan 2026)

Products & Services of Semler Scientific

Semler Scientific offers a comprehensive portfolio of products and services, including QuantaFlo.

QuantaFlo
Diagnostic Device

Portable tool for early detection of peripheral arterial disease.

Funding Insights of Semler Scientific

  • Total Rounds 1
  • Last Round Post-IPO β€” $498,600
  • First Round $498,600

    (Mar 2015)

All 1 funding rounds of Semler Scientific with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2015$498,600Post-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Semler Scientific

Semler Scientific has secured backing from 1 investor. Prominent investors backing the company include Strive.

All
InvestorDescriptionFounded YearDomainLocation
Diversified investment management is conducted by Strive since 2022.
2022strive.comColumbus, United States
Premium access

Investor details for Semler Scientific

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Semler Scientific

40 people are tracked at Semler Scientific (16 in leadership, 24 in team); the tracked headcount is 79.

NameRoleGroup
Lauren Liscinski
Director Of Instructional TechnologyLeadership
Candice Videña Nevarez
Senior Executive Administrator To Chief Operating OfficerLeadership
Lora Kelly
Human Resources Business Operations PartnerLeadership
Johnny Bemma
Chief Executive OfficerLeadership
Sandy A.
Director, Product ManagementLeadership
Gena D. Parker
Vice President, Ra, QA & ComplianceLeadership
Gretchen Cunliffe-Owen
Executive Director - Customer EducationLeadership
Lisa McDermott
Senior Director Human ResourcesLeadership
Charmayne Domingo
Vice President Of Strategic SalesLeadership
Benjamin Tucker
Director, Technical Solutions & IT SupportLeadership
Vanessa Aguilera
Vice President OperationsLeadership
Jennifer Oliva Herrington
Chief Operating OfficerLeadership
Sherry Guthrie
Vice President Of Clinical ServicesLeadership
Cindy Guinasso Hcemba
Senior Vice President Business DevelopmentLeadership
Salvador Esquivias
Director Of Data OperationsLeadership
Julie Whitworth
Vp, Information Technology And ServicesLeadership
Dennis Fedorov
Software Test EngineerTeam
Maria Tam Tran
Quality Assurance EngineerTeam
Mauricio P.
Technical Support SpecialistTeam
Eidel Dacquel
Avp, Security & Information SystemsTeam

20 more people are available in the full profile.

Premium access

Complete people profiles for Semler Scientific

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Semler Scientific

Semler Scientific is a publicly listed company on the NASDAQ with ticker symbol SMLR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date21 Feb 2014
  • Listed onNASDAQ: SMLR
  • Listed entitySemler Scientific, Inc.
  • Exchange sectorHealth technology
  • ISINUS81684M1045
  • Share price$20.33 (-4.87% on the day) · 2026-01-20
  • Market capitalisation$310.7M
  • Price to earnings7.3
  • EPS (diluted, trailing year)$2.78
  • Volume (last session)1,624,179
  • Analyst consensusStrong buy

Financials of Semler Scientific

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2024$56.3M$40.9M$21.5M
2023$68.2M$20.6M$23.6M
2022$56.7M$14.3M$17.8M
2021$53.0M$17.2M$20.1M
2020$38.6M$14.0M$16.5M
Premium access

Detailed financial statements for Semler Scientific

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Semler Scientific

4 dated milestones of Semler Scientific across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Semler Scientific is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $499K.
  4. Exit Acquired by Strive.

Web traffic of Semler Scientific

The website of Semler Scientific (semlerscientific.com) receives about 24.5K visits a month.

  • Monthly visits
    24.5K

    ▲ 36.5% vs previous month

Similar websites

Websites whose visitors overlap most with Semler Scientific. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lumenis.com
100%
74.9K#471,392View details
inogen.com
92%
160.2K#259,941View details

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Semler Scientific (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Semler Scientific

Premium access

Complete news archive for Semler Scientific

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Semler Scientific

Semler Scientific was founded in 2007 and raised its 1st funding round 8 years after it was founded.

Semler Scientific is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Semler Scientific has 79 employees.

Annual revenue of Semler Scientific is $56.29M as on Dec 31, 2024.

Semler Scientific was established in 2007 in San Jose, United States, within the medical device sector. Focus is placed on creating in-office tools for detecting peripheral arterial disease through blood flow assessments. QuantaFlo is utilized as a primary point-of-care test, while WellChec serves as a platform for screening multiple chronic conditions. Operations emphasize accessible diagnostic services for healthcare providers across the region.

Semler Scientific offers QuantaFlo.

Yes, Semler Scientific is publicly traded on NASDAQ under the ticker symbol SMLR.

Semler Scientific has 1 investor. Key investors include Strive.

Semler Scientific operates through Semler Scientific, Inc..

Yes. Semler Scientific was acquired by Strive in January 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available